PMS-LURASIDONE

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 1806ddc9a322c229
Drug Approval Canada Name: PMS-LURASIDONE
Product Name: PMS-LURASIDONE
Status: Marketed
Status Date: 2022-05-02
Original Market Date: 2022-05-02
Din: 02505916
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.08.04
Atc Original: N05AE05 LURASIDONE
Atc Name: n 05 ae 05
Aig Number: 0153185003
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

LURASIDONE HYDROCHLORIDE

120 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1806ddc9a322c229

Type

Standard